Skip to content

Journal · Immunology · Updated 22 November 2026

Seminars in Immunopathology

Read Seminars in Immunopathology articles on DeepDyve. No university library needed.

Seminars in Immunopathology publishes reviews on how the immune system drives disease, from Paneth cells in inflammatory bowel disease and PD-1 on T cells to the gut–lung axis and the immune effects of extreme heat. Springer Nature publishes it. It was previously published as Springer Seminars in Immunopathology. A DeepDyve subscription lets you read it in full, alongside millions of articles from other journals licensed from publishers including Springer Nature.

Then $59 a month or $499 a year. A credit card is required; cancel during the trial and you won’t be charged. You read articles online; PDFs are sold separately.

Personal plans aren’t for business use. Reading for work? See Enterprise.

Cover of Seminars in Immunopathology
Journal cover

Seminars in Immunopathology at a glance

Full title
Seminars in Immunopathology
Former title
Springer Seminars in Immunopathology
Abbreviation (NLM)
Semin Immunopathol
Publisher
Springer Nature
Print ISSN
1863-2297
Online ISSN (eISSN)
1863-2300
Current title since
2007
Subjects
Allergy and Immunology, Pathology
Access model
Hybrid (52% free to read in 2026)

Ways to access Seminars in Immunopathology

52% of the articles Seminars in Immunopathology published from January 1 to November 20, 2026 are open access and free to read. For the rest, look for the authors’ manuscript, check a library, or read them on DeepDyve.

  1. Open access articles. 52% of Seminars in Immunopathology articles published from January 1 to November 20, 2026 carry a Creative Commons license, per Crossref, and are free to read. They’re marked “Open access” below.
  2. The authors’ accepted manuscript. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication.
  3. Ask the authors. Authors can also share a free, read-only link to their published article through Springer Nature’s SharedIt, so it’s worth asking the authors directly.
  4. NIH-funded research. For papers accepted on or after July 1, 2025, the US National Institutes of Health requires the accepted manuscript in PubMed Central, free with no embargo from the official publication date.
  5. A library. Your university, hospital or public library may subscribe to Seminars in Immunopathology. Check its journal list and whether it offers remote access.
  6. DeepDyve. Read Seminars in Immunopathology articles online for $59 a month or $499 a year after a free first month. Articles marked LitStream below are in DeepDyve’s LitStream collection, which a subscription lets you read online. PDFs are sold separately, and availability varies by article.

Sources: Springer Nature self-archiving policy; NIH Public Access Policy; open access share from Crossref license data.

Impact factor and metrics

Seminars in Immunopathology’s 2025 Journal Impact Factor is 11.5, and its 5-year Impact Factor is 12.2.

11.5

Journal Impact Factor (2025)

12.2

5-year Impact Factor (2025)

16 days

Median time to first decision

Source: journal metrics on the Seminars in Immunopathology homepage (Springer Nature), checked November 22, 2026. Impact Factor from Clarivate Journal Citation Reports.

Recent Seminars in Immunopathology research worth reading

Published March to September 2026. Summaries describe what the authors report.

  1. Open accessGut immunity · IBD

    Paneth cells as orchestrators of epithelial barrier defense and emerging therapeutic targets in inflammatory bowel disease

    The authors review how Paneth cells at the base of intestinal crypts defend against microbes and support stem cells, how their dysfunction is linked to dysbiosis and inflammatory bowel disease, and emerging therapies aimed at restoring them.

    Erkert et al. · Seminars in Immunopathology, published online March 16, 2026 · DOI 10.1007/s00281-026-01068-x

  2. LitStreamT cells · Immune checkpoints

    PD-1⁺ CD8⁺ T cells: roles of PD-1 beyond an exhaustion marker

    The authors review evidence that PD-1⁺CD8⁺ T cells are a varied, adaptable population rather than simply exhausted cells, and discuss how PD-1 shapes their fate and function in cancer, chronic infections and autoimmune diseases.

    Chen et al. · Seminars in Immunopathology, published online July 7, 2026 · DOI 10.1007/s00281-026-01078-9

  3. Open accessAcute lung injury · Microbiota

    Gut microbiota–immune–metabolic crosstalk in acute lung injury: integrating the gut–lung axis from mechanism to therapeutic targeting

    The authors review how a disrupted gut barrier and microbial metabolites such as short-chain fatty acids and bile acids shape immune responses in acute lung injury and ARDS, and discuss therapies including fecal microbiota transplantation and metabolic interventions.

    Wu et al. · Seminars in Immunopathology, published online September 10, 2026 · DOI 10.1007/s00281-026-01081-0

  4. LitStreamClimate change · Immune regulation

    Climate change-associated heat extremes and immune dysregulation: emerging links with autoimmunity, allergy, and infectious diseases

    The authors review evidence that heat extremes, alone or with air pollution, can weaken epithelial barriers, reduce B-cell responses and raise inflammatory signaling, and discuss what this means for allergy, autoimmunity and infectious diseases.

    Fragkou et al. · Seminars in Immunopathology, published online May 11, 2026 · DOI 10.1007/s00281-026-01075-y

  5. LitStreamAsthma · Microbial metabolites

    Butyrate remodels the immune-epigenetic-gut-lung axis: Emerging mechanisms and therapeutic perspectives in asthma

    The authors review how butyrate, a gut microbial product of dietary fiber, shapes dendritic cell, macrophage and T cell function and gene activity through epigenetic mechanisms, linking gut microbes to airway inflammation in asthma and pointing to new treatments.

    Xie et al. · Seminars in Immunopathology, published online April 6, 2026 · DOI 10.1007/s00281-026-01069-w

See every Seminars in Immunopathology article on DeepDyve

Questions about Seminars in Immunopathology

How can I read Seminars in Immunopathology articles without a subscription?

52% of Seminars in Immunopathology articles published from January 1 to November 20, 2026 are open access and free to read. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication. Your library may also subscribe. DeepDyve lets you read Seminars in Immunopathology articles online for $59 a month or $499 a year after a free first month.

What is the abbreviation for Seminars in Immunopathology?

Seminars in Immunopathology’s NLM (PubMed) abbreviation is Semin Immunopathol.

What is the ISSN of Seminars in Immunopathology?

The print ISSN is 1863-2297 and the online ISSN is 1863-2300.

What is the impact factor of Seminars in Immunopathology?

Seminars in Immunopathology’s Journal Impact Factor is 11.5 (2025), and its 5-year Impact Factor is 12.2, according to Springer Nature’s published metrics.

Is Seminars in Immunopathology open access?

Seminars in Immunopathology is a hybrid journal: authors can choose to publish open access or under the subscription model. From January 1 to November 20, 2026, 13 of 25 Seminars in Immunopathology articles (52%) carry a Creative Commons license, per Crossref.

Seminars in Immunopathology articles on DeepDyve are licensed from Springer Nature. Journal facts as of 22 November 2026.

Start reading Seminars in Immunopathology today

One month free, then less than $2 a day. Seminars in Immunopathology, plus millions of articles from thousands of journals.

Start free month

Like this: